Use of sentinel lymph node biopsy with patent blue labeling and radiocolloid in patients with endometrial cancer;Uso del ganglio centinela con azul patente: Y radiofármaco en pacientes con cáncer de endometrio

Revista Venezolana de Oncologia

Volumn 21, Issue 1, 2009, Pages 3-10

  Zénzola, Víctor ^a   González, Claudia ^a   Lander, Jorge Sánchez ^a   Contreras, Itza ^a   Medina, Francisco ^a   Castillo, Jorge ^a   Chacón, Marcos ^a   Vásquez, Jesús ^a   Vento, Giovanni ^a  

^a Thoracic Oncology Section   (Venezuela)

Author keywords

Endometrial cancer; Radio colloid; Sentinel node biopsy

Indexed keywords

BLEU PATENTE; DISULFINE BLUE; EOSIN; HEMATOXYLIN; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CLINICAL ARTICLE; DISEASE SEVERITY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; LYMPH NODE METASTASIS; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; SALPINGOOOPHORECTOMY; SENTINEL LYMPH NODE BIOPSY; STAINING;

EID: 67650367659     PISSN: 07980582     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Greenlee RT, Hill Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;(51):15-36.
2. Ministerio del Poder Popular para la Salud (Venezuela). Anuario de Epidemiología y Estadística Vital. Caracas: MSDS; 2003. Disponible en: URL: http://www.msds.gov.ve/msdsnew/direccionesmsds/Epidemiologia/ Estadistica/Archivos/Anuarios.htm
3. FIGO. Corpus Cancer Stanging. Int J Gynecol Obstet. 1989;(28):90.
4. Barakat R, Lev G, Hummer A, Sonoda Y, Chi D, Alektiar K, et al. 20 year experience in the management of endometrial cancer. A change in surgical and postoperative radiation approaches. Gyn Oncol. 2007;(105):150-156.
5. Benedetti-Panicci P, Maneschi F, Cutillo G. Linfadenectomía pélvica y paraórtica. En: Peñalver M, Méndez L, Angioli R, editores. Oncología ginecológica. Clínicas Quirúrgicas de Norteamérica. México: Mc Graw Hill Latinoamericana; 2001.p. 865-884.
6. Barranger E, Cortez A, Grahek D, Callard P, Uzan S, Darai E. Laparoscopic sentinel procedure using a combination of patent blue an radiocolloid in women with endometrial cancer. Ann Surg Oncol. 2004;11(3):344-349. (Pubitemid 40486777)
7. Abu Rustum NR, Alektiar K, Iasonos A, Sonoda S, Aghajanian C. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignances: A 12 year experience at Memorial D Sloan-Kettering Cancer Center. Gynecol Oncol. 2006;(103):714-718. (Pubitemid 44602163)
8. De Hullu JA, Hollema H, Piers DA, Verheijen RH, van Diest PJ, Mourits MJ, et al. Lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol. 2000;(18):2811-2816. (Pubitemid 30620069)
9. Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001;(83):276-281. (Pubitemid 33033066)
10. Levenback C, Coleman RL, Burke TW, Lin WM, Erdman W, Deavers M, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002;(20):688-693. (Pubitemid 34111375)
11. Barranger E, Grahek D, Cortez A, Uzan S, Darai E. Laparoscopic sentinel node procedure in patients with cervical cancer. J Clin Oncol. 2002;(20):2602-2603.
12. Barranger E, Grahek D, Cortez A, Talbot JN, Uzan S, Darai E. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma. Cancer. 2003;(97):3003-3009. (Pubitemid 36676254)
13. Echt ML, Finan MA, Hoffman MS, Kline RC, Roberts WS, Fiorica JV. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. J South Med. 1999;92:204-208. (Pubitemid 29093751)
14. Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gerhenson D. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in patients with high risk endometrial cancer: Results of a pilot study. Gynecol Oncol. 1996;62:169-173. (Pubitemid 26274795)
15. 99m Tc colloid and blue dye in patients with endometrial cancer. Tumori. 2002;88(Suppl):9-10.
16. Lelievre L, Cammate S, le Frere MA, Kerrou K, Froissant S, Taurelle R, et al. Sentinel node biopsy in cervix and corpus uteri cancers. Int J Gynecol Cancer. 2004;14:271-278.
17. Niikura H, Okamura C, Utsunomiya H, Yoshinaga K, Akahira J, Ito K, et al. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol. 2004;92:669-674. (Pubitemid 38183161)
18. Maccauro M, Lucignani G, Aliberti G, Villano C, Castellani MR, Solima E, et al. Sentinel lymph node detection following peritumoral injection of 99 m-Tc labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Imaging. 2005;32:569-574. (Pubitemid 41214200)
19. Delaloye J, Pampallona S, Chardonnens E, Fiche M, Lehr I, De Grandi P, et al. A. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol Oncol. 2007;106:89-93.
20. Wong S, Edwards MJ, Chao C, Tutle TM, Noyes R, Carlson DJ, et al. Sentinel lymph nodes biopsy of breast cancer. Impact of the number of SN removed on the false negative rate. J Am Coll Surg. 2001;192:684-689. (Pubitemid 32506495)
21. Yabushita H, Shimazu M, Yamada H, Sawaguchi K, Nogushi M, Nakanishi M. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol. 2001;72:453. (Pubitemid 32158450)